免責事項:アナリストのレーティングおよび目標株価は、情報提供のみを目的としてLSEG Data & Analyticsが提供するものであり、投資助言を構成するものではありません。
Smith & Nephew PLCの注目ポイント
強みリスク
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
企業コードSNN
企業名Smith & Nephew PLC
最高経営責任者「CEO」Mr. Deepak S. Nath
ウェブサイトhttps://www.smith-nephew.com/
よくある質問
Smith & Nephew PLC(SNN)の現在の株価はいくらですか?
Smith & Nephew PLC(SNN)の現在の株価は33.420です。
Smith & Nephew PLCのティッカーシンボルは何ですか?
Smith & Nephew PLCのティッカーシンボルはSNNです。
Smith & Nephew PLCの52週高値はいくらですか?
Smith & Nephew PLCの52週高値は38.790です。
Smith & Nephew PLCの52週安値はいくらですか?
Smith & Nephew PLCの52週安値は23.690です。
Smith & Nephew PLCの時価総額はいくらですか?
Smith & Nephew PLCの時価総額は14.64Bです。
Smith & Nephew PLCの純利益はいくらですか?
Smith & Nephew PLCの純利益は412.00Mです。
Smith & Nephew PLC (SNN) の現在の評価は「買い」、「ホールド」、「売り」のどれですか?